Clinical Trial Update: Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating long-term safety of linaclotide for functional constipation or irritable bowel syndrome with constipation has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: AbbVie | Conditions: Irritable Bowel Syndrome With Constipation, Functional Constipation | Phase 3 | Status: COMPLETED | Results posted: 2026-01-06